BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20970196)

  • 1. Applying comparative effectiveness research methods in bipolar disorders.
    McCombs JS; Ganapathy V; Zolfaghari S
    J Affect Disord; 2011 Apr; 130(1-2):145-54. PubMed ID: 20970196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of drug treatment history on comparative effectiveness research in schizophrenia.
    McCombs J; Zolfaghari S; Ganapathy V
    Value Health; 2011; 14(5):679-86. PubMed ID: 21839406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving mental health treatments through comparative effectiveness research.
    Wang PS; Ulbricht CM; Schoenbaum M
    Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing the clinical utility of comparative effectiveness research.
    Umscheid CA
    Clin Pharmacol Ther; 2010 Dec; 88(6):876-9. PubMed ID: 20962776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to answering critical CER questions.
    Kinnier CV; Chung JW; Bilimoria KY
    Cancer Treat Res; 2015; 164():1-14. PubMed ID: 25677015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
    McCombs JS; Ahn J; Tencer T; Shi L
    J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational methods in comparative effectiveness research.
    Concato J; Lawler EV; Lew RA; Gaziano JM; Aslan M; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e16-23. PubMed ID: 21184862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics.
    Lang K; Korn J; Muser E; Choi JC; Abouzaid S; Menzin J
    J Med Econ; 2011; 14(2):217-26. PubMed ID: 21370989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacology of pediatric bipolar disorder.
    Hamrin V; Iennaco JD
    Expert Rev Neurother; 2010 Jul; 10(7):1053-88. PubMed ID: 20586689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders.
    Warden D; Trivedi MH; Carmody TJ; Gollan JK; Kashner TM; Lind L; Crismon ML; Rush AJ
    Psychol Med; 2010 Jun; 40(6):955-65. PubMed ID: 19785919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
    J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
    Seemüller F; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Riedel M
    J Clin Psychiatry; 2010 Nov; 71(11):1425-33. PubMed ID: 20816028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2007; 76(2):77-88. PubMed ID: 17230048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for bipolar depression.
    Hirschfeld RM; Fochtmann LJ; McIntyre JS
    Am J Psychiatry; 2005 Aug; 162(8):1546-7; author reply 1547-8. PubMed ID: 16055788
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressants for bipolar depression.
    Ghaemi SN; Goodwin FK
    Am J Psychiatry; 2005 Aug; 162(8):1545-6; author reply 1547-8. PubMed ID: 16055786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacotherapeutic trends at the beginning of the millennium in Hungary. Pharmacotherapy for bipolar patients, I].
    Kovács G
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):13-8. PubMed ID: 15125309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.